Literature DB >> 16120409

The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations.

Andrea L Gropman1.   

Abstract

Mitochondrial disorders are caused by mutations of nuclear or mitochondrial DNA encoded genes involved in oxidative phosphorylation (OXPHOS). Mutations in these critical genes are associated with specific clinical syndromes with diverse presentations (DiMauro and Schon, 2003. NEJM 348, 2656; Hart et al., 2002. Mitochondrial Disorders in Neurology). Since mitochondria are present in many of our organs and play a key role in energy metabolism, mitochondrial encephalomyopathies often present as multisystem disorders which may manifest with neurologic, cardiac, endocrine, gastrointestinal, hepatic, renal and/or hematologic involvement (DiMauro and Bonilla, 1997. The Molecular and Genetic Basis of Neurological Disease; Vu et al., 2002. Neurol. Clin. N. Am. 20, 809). This chapter will address adult and childhood onset mitochondrial DNA encephalomyopathies, characteristic clinical presentations, as well as their molecular characterization.

Entities:  

Year:  2004        PMID: 16120409     DOI: 10.1016/j.mito.2004.07.009

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  8 in total

1.  Mutations in cytochrome c oxidase subunit VIa cause neurodegeneration and motor dysfunction in Drosophila.

Authors:  Wensheng Liu; Radhakrishnan Gnanasambandam; Jeffery Benjamin; Gunisha Kaur; Patricia B Getman; Alan J Siegel; Randall D Shortridge; Satpal Singh
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

Review 2.  New frontiers in neuroimaging applications to inborn errors of metabolism.

Authors:  Morgan J Prust; Andrea L Gropman; Natalie Hauser
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

3.  Central precocious puberty may be a manifestation of endocrine dysfunction in pediatric patients with mitochondrial disease.

Authors:  Hyun-Wook Chae; Ji-Hoon Na; Ahreum Kwon; Ho-Seong Kim; Young-Mock Lee
Journal:  Eur J Pediatr       Date:  2020-09-10       Impact factor: 3.183

Review 4.  Neuroimaging in mitochondrial disorders.

Authors:  Andrea L Gropman
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

5.  Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Authors:  Andrea L Gropman; Afrouz Anderson
Journal:  J Transl Genet Genom       Date:  2020-11-13

Review 6.  Pulmonary hypertension as a manifestation of mitochondrial disease: A case report and review of the literature.

Authors:  Shan Xu; Xiaoling Xu; Jisong Zhang; Kejing Ying; Yuquan Shao; Ruifeng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  Epilepsia partialis continua in mitochondrial dysfunction: Interesting phenotypic and MRI observations.

Authors:  Kalyani Karkare; Sanjib Sinha; Shivashankar Ravishankar; Narayanappa Gayathri; T Chikkabasavaiah Yasha; Manoj K Goyal; Joy Vijayan; Ayyasamy Vanniarajan; Kumarswamy Thangaraj; Arun B Taly
Journal:  Ann Indian Acad Neurol       Date:  2008-07       Impact factor: 1.383

8.  The SFT-1 and OXA-1 respiratory chain complex assembly factors influence lifespan by distinct mechanisms in C. elegans.

Authors:  Sara Maxwell; Joanne Harding; Charles Brabin; Peter J Appleford; Ruth Brown; Carol Delaney; Garry Brown; Alison Woollard
Journal:  Longev Healthspan       Date:  2013-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.